Sderot compensation requests granted

The country's central investment has approved 14 requests for financial aid from companies in the Sderot region that have been affected by the recent increase in Kassam rocket attacks, the Industry, Trade and Labor Ministry said Monday.

By MATTHEW KRIEGER
June 5, 2007 08:19

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

The country's central investment has approved 14 requests for financial aid from companies in the Sderot region that have been affected by the recent increase in Kassam rocket attacks, the Industry, Trade and Labor Ministry said Monday. The total value of the aid package is worth more than NIS 155m. and includes companies in Sderot, southern Ashkelon and the northern Negev. Hezi Zaieg, the director of the investment office said the aid allocated to the companies will help them overcome the extensive losses they have suffered as a result of the attacks.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS